PRECISION OPTICS CORPORATION, INC. Business Acquisition, Pro Forma Net Income (Loss)
PRECISION OPTICS CORPORATION, INC. (POCI) reported Business Acquisition, Pro Forma Net Income (Loss) of -$398.43 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-09-28
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-03-31 was -$398.43K.
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for the quarter ending 2022-12-31 was $634.42K.
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for the quarter ending 2022-09-30 was -$73.51K.
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for the quarter ending 2022-06-30 was $269.30K.
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for fiscal 2022 was -$871.12K, a 1020.68% decline from fiscal 2021.
- PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma net income (loss) for fiscal 2021 was $94.62K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$398.43K 10-Q · filed 2023-05-15 | $235.99K derived: sum of 2 quarters · filed 2023-05-15 | -$48.49K 10-Q · filed 2023-05-15 | $431.77K derived: sum of 4 quarters · filed 2023-09-28 |
| 2022-12-31 | $634.42K 10-Q · filed 2023-02-14 | $560.91K 10-Q · filed 2023-02-14 | $830.21K derived: sum of 3 quarters · filed 2023-09-28 | $716.31K derived: sum of 4 quarters · filed 2023-09-28 |
| 2022-09-30 | -$73.51K 10-Q · filed 2022-11-14 | $195.79K derived: sum of 2 quarters · filed 2023-09-28 | $81.89K derived: sum of 3 quarters · filed 2023-09-28 | -$425.13K derived: sum of 4 quarters · filed 2023-09-28 |
| 2022-06-30 | $269.30K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $155.40K derived: sum of 2 quarters · filed 2023-09-28 | -$351.62K derived: sum of 3 quarters · filed 2023-09-28 | -$871.12K 10-K · filed 2023-09-28 |
| 2022-03-31 | -$113.90K 10-Q · filed 2023-05-15 | -$620.91K derived: sum of 2 quarters · filed 2023-05-15 | -$1.14M 10-Q · filed 2023-05-15 | -$1.43M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$507.01K 10-Q · filed 2023-02-14 | -$1.03M 10-Q · filed 2023-02-14 | -$1.31M derived: sum of 3 quarters · filed 2023-02-14 | -$720.91K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$519.51K 10-Q · filed 2022-11-14 | -$807.57K derived: sum of 2 quarters · filed 2022-11-14 | -$213.90K derived: sum of 3 quarters · filed 2022-11-14 | -$435.21K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$288.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $305.60K derived: sum of 2 quarters · filed 2022-09-27 | $84.30K derived: sum of 3 quarters · filed 2022-09-27 | $94.62K 10-K · filed 2022-09-27 |
| 2021-03-31 | $593.67K 10-Q · filed 2022-05-16 | $372.36K derived: sum of 2 quarters · filed 2022-05-16 | $382.68K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | -$221.30K 10-Q · filed 2022-02-14 | -$210.99K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |